These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17257770)

  • 1. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis.
    Li Y; Liu FY; Peng YM; Li J; Chen J
    Med Hypotheses; 2007; 69(1):99-103. PubMed ID: 17257770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A target role for mast cell in the prevention and therapy of hepatic fibrosis.
    Shen DZ
    Med Hypotheses; 2008; 70(4):760-4. PubMed ID: 17919831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes.
    Jones SE; Gilbert RE; Kelly DJ
    J Diabetes Complications; 2004; 18(5):309-15. PubMed ID: 15337505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells and inflammatory kidney disease.
    Blank U; Essig M; Scandiuzzi L; Benhamou M; Kanamaru Y
    Immunol Rev; 2007 Jun; 217():79-95. PubMed ID: 17498053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
    Danilewicz M; Wagrowska-Danilewicz M
    Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
    Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2001; 52(4):211-7. PubMed ID: 11915183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of interstitial mast cells in AA and AL renal amyloidosis.
    Danilewicz M; Wagrowska-Danilewicz M
    Pathol Res Pract; 2002; 198(6):413-9. PubMed ID: 12166898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies.
    Yang T; Vesey DA; Johnson DW; Wei MQ; Gobe GC
    Transl Res; 2007 Jul; 150(1):40-50. PubMed ID: 17585862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct development of functionally mature tryptase/chymase double-positive connective tissue-type mast cells from primate embryonic stem cells.
    Ma F; Kambe N; Wang D; Shinoda G; Fujino H; Umeda K; Fujisawa A; Ma L; Suemori H; Nakatsuji N; Miyachi Y; Torii R; Tsuji K; Heike T; Nakahata T
    Stem Cells; 2008 Mar; 26(3):706-14. PubMed ID: 17991916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mast cells in progressive renal diseases.
    Holdsworth SR; Summers SA
    J Am Soc Nephrol; 2008 Dec; 19(12):2254-61. PubMed ID: 18776124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine release from human buffy coat-derived mast cells.
    Wang XS; Lau HY
    Int Immunopharmacol; 2007 Apr; 7(4):541-6. PubMed ID: 17321478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced mast cell chymase expression in human idiopathic interstitial pneumonia.
    Hirata K; Sugama Y; Ikura Y; Ohsawa M; Inoue Y; Yamamoto S; Kitaichi M; Ueda M
    Int J Mol Med; 2007 Apr; 19(4):565-70. PubMed ID: 17334631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin: at the heart of the mast cell.
    Reid AC; Silver RB; Levi R
    Immunol Rev; 2007 Jun; 217():123-40. PubMed ID: 17498056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47.
    Xia Z; Abe K; Furusu A; Miyazaki M; Obata Y; Tabata Y; Koji T; Kohno S
    Am J Nephrol; 2008; 28(1):34-46. PubMed ID: 17890856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure.
    Baba A; Tachi M; Ejima Y; Endo Y; Toyama H; Saito K; Abe N; Yamauchi M; Miura C; Kazama I
    Nephrology (Carlton); 2017 Feb; 22(2):159-167. PubMed ID: 26840502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis.
    OkoĊ„ K; Stachura J
    Pol J Pathol; 2007; 58(3):193-7. PubMed ID: 18074865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells.
    Park HH; Lee S; Son HY; Park SB; Kim MS; Choi EJ; Singh TS; Ha JH; Lee MG; Kim JE; Hyun MC; Kwon TK; Kim YH; Kim SH
    Arch Pharm Res; 2008 Oct; 31(10):1303-11. PubMed ID: 18958421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.